1. Cell Cycle/DNA Damage
  2. Folate Receptor (FR)
  3. 4A-BFA-11

4A-BFA-11 是一种叶酸靶向 PEG-MMAE 偶联物,对叶酸受体 α (FR-α) 具有特异性结合亲和力 (KD = 106.7 nM)。4A-BFA-11 通过结合聚乙二醇 (PEG) 介导的长循环 (EPR 效应) 和叶酸受体靶向作用,实现肿瘤富集。4A-BFA-11 在肿瘤部位发生酶切,释放活性有效载荷,从而实现精准作用。4A-BFA-11 在 HeLa 小鼠模型中,能高效地携带、靶向并控制 MMAE 在肿瘤组织中的释放。4A-BFA-11 可用于宫颈癌、卵巢癌和肺癌的研究。
(粉色: 靶蛋白配体;蓝色: E3 连接酶配体;黑色: 连接子)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

4A-BFA-11

4A-BFA-11 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 Folate Receptor (FR) 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

4A-BFA-11 is a folate-targeted PEG-MMAE conjugate that exhibits specific binding affinity for the folate receptor α (FR-α) (KD = 106.7 nM). 4A-BFA-11 achieves tumor enrichment by combining PEG-mediated long circulation (EPR effect) and folate receptor targeting. 4A-BFA-11 undergoes enzymatic cleavage at the tumor site to release the active payload, enabling precise action. 4A-BFA-11 sefficiently carries, targets, and controls the release of MMAE in tumor tissues in a HeLa mouse model. 4A-BFA-11 can be used for cervical cancer, ovarian cancer, and lung cancer research[1]. (Pink: Target protein ligand; Blue: E3 ligase ligand; Black: linker).

IC50 & Target[1]

FR-α

106.7 nM (Kd)

体外研究
(In Vitro)

4A-BFA-11 (72 小时) 在 HeLa、SK-OV-3 和 A549 细胞中表现出抗增殖活性,IC50 分别为 37.62、28.8 和 15.1 nM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

药代动力学
(Parmacokinetics)
Species Dose Route T1/2 Cmax AUC0-t AUC0-∞ Vz-F_obs CL/F
Mice[1] 1.5 mg/kg i.v. 3.04 h 6783.19 ng/mL 21168.40 ng·h/mL 21352.07 ng·h/mL 229.71 mL/kg 70.41 mL/h/kg
体内研究
(In Vivo)

4A-BFA-11 (0.4 和 0.8 mg/kg,静脉注射,每周一次,持续 2 周) 可抑制 HeLa 小鼠宫颈癌模型中的肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c nude mice (5-6 weeks) inoculated with HeLa graft tumors in the right axilla[1]
Dosage: 0.4 and 0.8 mg/kg
Administration: i.v., once weekly for 2 weeks
Result: Resulted in stronger antitumor effects with a tumor growth inhibition rate (T/C%) of 67.1% at 0.4 mg/kg.
Achieved pronounced antitumor effects with a T/C% of 95.9% at 0.8 mg/kg.
Showed no significant body weight loss and no significant changes in blood parameters.
Induced mild hepatitis at 0.4 mg/kg, characterized by trace inflammatory cell infiltration predominantly composed of lymphocytes and granulocytes.
Exhibited mild sinusoidal dilatation in the spleen, and the low-dose group showed slight adhesion of the white pulp.
分子量

2349.72

Formula

C113H173N23O31

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
4A-BFA-11
目录号:
HY-180557
需求量: